To analyse the relation between granulocyte donors blood counts after administration of medication given to increase Total Leucocyte Count and its effect on granulocyte product quality.
Not Applicable
Completed
- Registration Number
- CTRI/2022/08/044779
- Lead Sponsor
- oble Diagnostics Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 42
Inclusion Criteria
All granulocyte donors who fulfill the eligibility criteria for apheresis granulocyte donation and are mobilized using standard mobilizing agents and who undergo granulocyte harvest procedure in DTM.
Exclusion Criteria
1.Granulocyte donors who do not qualify eligibility criteria.
2.Granulocyte harvest procedure aborted due to any issues encountered during the procedure.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To prospectively analyze effect of mobilizing agents on yield of apheresis granulocyte concentrate, also its effect on granulocyte donors hematological parameters.Timepoint: 6months
- Secondary Outcome Measures
Name Time Method To analyze mobilization and procedure related adverse effects on granulocyte donors.Timepoint: 6months